Crinetics Pharmaceuticals Inc (CRNX) - News Archive

Showing 3 of 23 results.

Crinetics Pharmaceuticals' Paltusotine Shows Promise in Carcinoid Syndrome Treatment, But Revenue Decline Raises Questions

Crinetics Pharmaceuticals Inc., a leading biopharmaceutical company, recently announced positive initial findings from an ongoing open-label Phase 2 study of their latest innovative drug, Paltusotine. This breakthrough...

Dec 18, 2023 • Major Pharmaceutical Preparations Industry Clinical Study

Crinetics Pharmaceuticals Empowers New Non-Executive Employees with Inducement Grants, Fueling Growth and Innovation

Crinetics Pharmaceuticals Grants Stock Options to New Non-Executive EmployeesSan Diego-based pharmaceutical company, Crinetics Pharmaceuticals Inc., announced on December 11, 2023, its recent inducement grants under Nas...

Dec 11, 2023 • Major Pharmaceutical Preparations Industry Shares

Crinetics Pharmaceuticals Raises $350 Million through Upsized Public Offering, Set to Revolutionize Endocrine Treatment

Crinetics Pharmaceuticals Announces Upsized Public Offering of Common Stock to Fuel Continued GrowthAs of the writing of this article, Crinetics Pharmaceuticals Inc s share price stands at $26.8, showcasing an impressiv...

Sep 13, 2023 Shares